CAR-TCR Summit Europe 2025

This summit will focus on the next-generation innovations in cell therapy. Attendees can expect discussions on the latest breakthroughs, particularly in treating solid tumours and autoimmune diseases, with recent approvals from Iovance, Adaptimmune, and Kite marking significant progress. The event will address key challenges, such as safety concerns, high production costs, and effective tumour targeting.

The summit will also feature focused days on Autoimmune and Regulatory strategies, with insights from leaders like Cabaletta Bio, GentiBio, and Sana Biotech. With a comprehensive agenda covering Discovery, Clinical Development, and Process & Analytics, this summit offers a platform for collaboration, innovation, and advancing cell therapy towards first-line treatments for both oncological and non-oncological conditions.